$5.06 Billion is the total value of Rock Springs Capital Management LP's 156 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 47.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVAX | Sell | NOVAVAX INC | $96,601,000 | +15.6% | 455,000 | -1.3% | 1.91% | +4.7% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $96,106,000 | -6.1% | 240,000 | -12.7% | 1.90% | -14.9% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $51,542,000 | -7.0% | 319,085 | -1.4% | 1.02% | -15.8% |
| PRTA | Sell | PROTHENA CORP PLC | $48,844,000 | +68.1% | 950,091 | -17.9% | 0.96% | +52.2% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $24,390,000 | -12.2% | 1,000,000 | -7.1% | 0.48% | -20.5% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $16,994,000 | -83.8% | 791,133 | -53.3% | 0.34% | -85.3% |
| PRTK | Sell | PARATEK PHARMACEUTICALS INC | $11,285,000 | -5.1% | 1,654,714 | -1.8% | 0.22% | -13.9% |
| STTK | Sell | SHATTUCK LABS INC | $9,088,000 | -20.0% | 313,499 | -19.3% | 0.18% | -27.4% |
| ATHA | Sell | ATHIRA PHARMA INC | $7,662,000 | -47.2% | 748,202 | -5.1% | 0.15% | -52.2% |
| NUVB | Sell | NUVATION BIO INC | $2,248,000 | -46.5% | 241,485 | -39.9% | 0.04% | -52.2% |
| LSAQ | Exit | LIFESCI ACQUISITION II CORP | $0 | – | -206,200 | -100.0% | -0.05% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -119,114 | -100.0% | -0.05% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -80,000 | -100.0% | -0.08% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -364,800 | -100.0% | -0.23% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -140,000 | -100.0% | -0.26% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -266,520 | -100.0% | -0.28% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -100,000 | -100.0% | -0.45% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -650,000 | -100.0% | -0.70% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -2,660,822 | -100.0% | -2.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-01 |
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.